VASTAREL MR 35 MG 30 TAB

* Modified-release tablets.
* Therapeutic indications:
& This drug is recommended in:
– preventive treatment of episodes of angina pectoris.
– adjuvant symptomatic treatment for vertigo and tinnutus (noises detected by the ear:
& whistling, buzzing, which do not correspond to any exterior sounds).
– adjuvant treatment of visual disorders of a circulatory origin.
* Contraindications:
& Do not take Vastarel MR if you are allergic to any of the constituents.
& The drug is generally not recommended during breastfeeding.
* Special warnings and Precautions:
& This drug is not a curative treatment for angina attacks, nor an initial treatment for
& unstable angina pectoris. It is not a treatment for myocardial infarction.
& In the event of an angina attack, inform your doctor. Tests may be required and your
& treatment may possibly be modified.
* Pregnancy and breastfeeding:
Pregnancy: It is preferable not to take this medicine during pregnancy. If you discover
& that you are pregnant whilst taking this medicine, consult your doctor as he alone can
& judge the necessity of continuing your treatment.
Breast-feeding: In the absence of data on excretion in breast milk, breast-feeding is not
& recommended during treatment.
& Ask your doctor’s or pharmacist’s advice before taking any medicine.
* Dosage and method of administration:
& Oral route.
& The usual dosage is 1 tablet in the morning and evening.
& Tablets should be swallowed with a glass of water at meal times.
& If you think that the effect of Vastarel MR is too strong or too weak, tallk to your doctor
& or pharmacist.